Oruka Therapeutics (ORKA) News Today $12.56 -0.31 (-2.41%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$12.58 +0.02 (+0.16%) As of 06/13/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ORKA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Oruka Therapeutics (NASDAQ:ORKA) Downgraded by Wall Street Zen to "Sell"June 15 at 3:05 AM | americanbankingnews.comWall Street Zen Downgrades Oruka Therapeutics (NASDAQ:ORKA) to SellWall Street Zen downgraded shares of Oruka Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday.June 14 at 1:41 AM | marketbeat.comMillennium Management LLC Makes New Investment in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Millennium Management LLC bought a new position in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 30,305 shares of the company's stock, vaJune 8, 2025 | marketbeat.comToronto Dominion Bank Takes Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Toronto Dominion Bank purchased a new position in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 58,332 shares of the company's stoJune 1, 2025 | marketbeat.comORKA Oruka Therapeutics, Inc.May 30, 2025 | seekingalpha.comQ2 EPS Estimate for Oruka Therapeutics Boosted by AnalystOruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) - Investment analysts at HC Wainwright boosted their Q2 2025 earnings per share (EPS) estimates for Oruka Therapeutics in a research note issued on Tuesday, May 27th. HC Wainwright analyst M. Kapoor now expects that the company will earn ($0.47May 30, 2025 | marketbeat.comNorthern Trust Corp Acquires Shares of 64,044 Oruka Therapeutics, Inc. (NASDAQ:ORKA)Northern Trust Corp acquired a new stake in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 64,044 shares of the company's stock, valued at approximately $1,242,000. NorMay 30, 2025 | marketbeat.comJefferies Financial Group Inc. Makes New $6.79 Million Investment in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Jefferies Financial Group Inc. purchased a new position in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 350,029 shares of the cMay 28, 2025 | marketbeat.comH.C. Wainwright Maintains Buy Rating on Oruka (ORKA) After the Early Start of OKRA-002 TrialMay 27, 2025 | insidermonkey.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Given Consensus Recommendation of "Buy" by AnalystsOruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) has been assigned a consensus recommendation of "Buy" from the ten ratings firms that are currently covering the stock, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy rating and two have assigned a strongMay 27, 2025 | marketbeat.com58,332 Shares in Oruka Therapeutics, Inc. (NASDAQ:ORKA) Purchased by Toronto Dominion BankToronto Dominion Bank acquired a new position in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 58,332 shares of the company's stock, valued at approximately $1,131,000. TorontoMay 26, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Raised to Hold at StockNews.comStockNews.com upgraded Oruka Therapeutics from a "sell" rating to a "hold" rating in a research note on Thursday.May 24, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Coverage Initiated by Analysts at BTIG ResearchBTIG Research started coverage on shares of Oruka Therapeutics in a report on Thursday. They set a "buy" rating and a $44.00 price objective on the stock.May 24, 2025 | marketbeat.comFrazier Life Sciences Management L.P. Grows Holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Frazier Life Sciences Management L.P. lifted its holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 22.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 583,327 shares of the company's stock afterMay 23, 2025 | marketbeat.comVR Adviser LLC Buys 200,000 Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA)VR Adviser LLC increased its stake in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 6.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,285,620 shares of the company's stock after acquiring an additional 200,000 shares during the periodMay 22, 2025 | marketbeat.comPoint72 Asset Management L.P. Cuts Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Point72 Asset Management L.P. lessened its holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 25.2% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 360,732 shares of the company's stock after selling 1May 22, 2025 | marketbeat.comOruka Therapeutics begins trial for psoriasis treatmentMay 21, 2025 | uk.investing.comOruka Therapeutics to Present at the Jefferies Global Healthcare ConferenceMay 21, 2025 | globenewswire.comOruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F AntibodyMay 20, 2025 | globenewswire.comWedbush Forecasts Reduced Earnings for Oruka TherapeuticsOruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) - Analysts at Wedbush reduced their Q2 2025 earnings estimates for shares of Oruka Therapeutics in a research report issued to clients and investors on Wednesday, May 14th. Wedbush analyst D. Nierengarten now forecasts that the company will posMay 20, 2025 | marketbeat.comRTW Investments LP Boosts Stock Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA)RTW Investments LP grew its stake in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 5.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,945,649 shares of the company's stock after purchasMay 18, 2025 | marketbeat.comPolar Capital Holdings Plc Buys New Stake in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Polar Capital Holdings Plc acquired a new position in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 550,000 shares of the company's stock, valued at approximMay 18, 2025 | marketbeat.comJanus Henderson Group PLC Boosts Stake in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Janus Henderson Group PLC increased its holdings in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 259.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 849,410May 18, 2025 | marketbeat.comTD Cowen Remains a Buy on Oruka Therapeutics (ORKA)May 17, 2025 | theglobeandmail.comWedbush Sticks to Its Buy Rating for Oruka Therapeutics (ORKA)May 17, 2025 | theglobeandmail.comParadigm Biocapital Advisors LP Boosts Stake in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Paradigm Biocapital Advisors LP lifted its holdings in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 13.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 819,660 shares of the company's stockMay 16, 2025 | marketbeat.comOruka Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 14, 2025 | globenewswire.comFairmount Funds Management LLC Has $65.38 Million Holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Fairmount Funds Management LLC lifted its position in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 5.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,371,922 shares of the company's stock after buyingMay 10, 2025 | marketbeat.comDeep Track Capital LP Sells 485,187 Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA)Deep Track Capital LP lessened its holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 39.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 750,000 shares of the company's stock after selling 485,187 shares during the period. Deep TMay 9, 2025 | marketbeat.comBraidwell LP Acquires 631,950 Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA)Braidwell LP raised its holdings in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 122.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,147,676 shares of the company's stock after acquiring an additional 631,950 shares during the perioMay 8, 2025 | marketbeat.comBlackstone Inc. Makes New Investment in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Blackstone Inc. bought a new position in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 240,174 shares of the company's stock, valued at approximately $4,657,000. Blackstone Inc. owned 0.69May 8, 2025 | marketbeat.comBarclays PLC Purchases Shares of 74,583 Oruka Therapeutics, Inc. (NASDAQ:ORKA)Barclays PLC purchased a new position in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 74,583 shares of the company's stock, valued atMay 6, 2025 | marketbeat.com683 Capital Management LLC Takes Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA)683 Capital Management LLC bought a new position in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 33,875 shares of the company's stock, valued at approximately $May 4, 2025 | marketbeat.comQ1 EPS Forecast for Oruka Therapeutics Reduced by AnalystOruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) - HC Wainwright decreased their Q1 2025 earnings per share (EPS) estimates for shares of Oruka Therapeutics in a report released on Monday, April 28th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings per sharMay 3, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Grows Stock Holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Price T Rowe Associates Inc. MD increased its holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 374.5% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,326,893 shares of the company's stock after buying an additioMay 3, 2025 | marketbeat.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Given Average Rating of "Buy" by BrokeragesOruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) has received an average rating of "Buy" from the nine brokerages that are presently covering the company, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy rating and two have given a strong buy rating to thMay 3, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for ORKA Q1 Earnings?Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 EPS estimates for Oruka Therapeutics in a research note issued to investors on Monday, April 28th. HC Wainwright analyst M. Kapoor forecasts that the company will post earnings of ($0.62) pMay 2, 2025 | marketbeat.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Shares Sold by Adage Capital Partners GP L.L.C.Adage Capital Partners GP L.L.C. cut its holdings in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 65.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 69,200 shares of the company's stock after seMay 2, 2025 | marketbeat.comOruka Therapeutics to Present at Bank of America Securities 2025 Health Care ConferenceApril 29, 2025 | globenewswire.comGeode Capital Management LLC Boosts Stock Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Geode Capital Management LLC grew its holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 2,348.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 342,418 shares of the company's stock after acquiring an additional 328,434 sApril 28, 2025 | marketbeat.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Shares Bought by SR One Capital Management LPSR One Capital Management LP lifted its stake in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 14.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 430,330 shares of the company's stock after acquiring aApril 19, 2025 | marketbeat.comOruka Therapeutics (ORKA) Projected to Post Quarterly Earnings on ThursdayOruka Therapeutics (NASDAQ:ORKA) will be releasing earnings before the market opens on Thursday, April 24, Financial Modeling Prep reports.April 18, 2025 | marketbeat.comKennedy Capital Management LLC Buys Shares of 60,494 Oruka Therapeutics, Inc. (NASDAQ:ORKA)Kennedy Capital Management LLC purchased a new position in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 60,494 shares of the company's stocApril 17, 2025 | marketbeat.comFmr LLC Increases Stock Holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA)Fmr LLC grew its holdings in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 17.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,512,300 shares of the company's stock after purchasing anApril 16, 2025 | marketbeat.comVanguard Group Inc. Acquires 1,572,853 Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA)Vanguard Group Inc. boosted its holdings in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 4,161.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 1,610,651 shares of the company's stock after acquiring an additional 1,572,853 shares durinApril 16, 2025 | marketbeat.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of "Buy" from AnalystsOruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) has been assigned a consensus rating of "Buy" from the nine analysts that are currently covering the firm, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy rating and two have given a strong buy rating to theApril 7, 2025 | marketbeat.comWe're Not Very Worried About Oruka Therapeutics' (NASDAQ:ORKA) Cash Burn RateMarch 8, 2025 | finance.yahoo.comOruka Therapeutics' (ORKA) "Outperform" Rating Reaffirmed at WedbushWedbush reaffirmed an "outperform" rating and issued a $40.00 price objective on shares of Oruka Therapeutics in a research report on Friday.March 8, 2025 | marketbeat.comOruka Therapeutics at Risk: Navigating Licensing Challenges and Partner RelianceMarch 8, 2025 | tipranks.comOruka Therapeutics announces preclinical data for ORKA-002March 7, 2025 | markets.businessinsider.com Get Oruka Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ORKA and its competitors with MarketBeat's FREE daily newsletter. Email Address ORKA Media Mentions By Week ORKA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORKA News Sentiment▼1.040.89▲Average Medical News Sentiment ORKA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORKA Articles This Week▼33▲ORKA Articles Average Week Get Oruka Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ORKA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies INDV News Today APGE News Today IRON News Today BHC News Today BEAM News Today ARQT News Today BHVN News Today SDGR News Today EWTX News Today JANX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORKA) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oruka Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oruka Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
